Opinion or commentary
This commentary paper from The Lancet Global Health defines a prescription for change in the approach of global health partners to research capacity building.
From the International Vaccines Task Force, this report develops a framework (for action by countries, development partners, research funders, research organisations and the private sector) for financing clinical research and trial capacity strengthening in low and middle-income countries. It focuses on the capacity to conduct and participate in late-stage vaccine trials during epidemic outbreaks. The report concludes in 15 recommendations with clear timeframes.